{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:08:49Z","timestamp":1782601729290,"version":"3.54.5"},"reference-count":13,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.clinthera.2014.06.002","type":"journal-article","created":{"date-parts":[[2014,6,27]],"date-time":"2014-06-27T20:16:01Z","timestamp":1403900161000},"page":"1303-1306","source":"Crossref","is-referenced-by-count":18,"title":["Levetiracetam as a Possible Contributor to Acute Kidney Injury"],"prefix":"10.1016","volume":"36","author":[{"given":"Danielle C.","family":"Spengler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia D.","family":"Montouris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna D.","family":"Hohler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2014.06.002_bib1","unstructured":"eHealthMe. Real world drug outcomes. http:\/\/www.ehealthme.com\/. Accessed August 31, 2011."},{"key":"10.1016\/j.clinthera.2014.06.002_bib2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0163-7258(99)00052-2","article-title":"Pharmacokinetic profile of levetiracetam: toward ideal characteristics","volume":"85","author":"Patsalos","year":"2000","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2014.06.002_bib3","first-page":"S57","article-title":"Safety profile of levetiracetam","volume":"Suppl 1","author":"Arroyo","year":"2003","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.clinthera.2014.06.002_bib4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2165\/00003088-199631010-00003","article-title":"The clinical pharmacokinetics of the newer antiepileptic drugs: focus on topiramate, zonisamide, and tiagabine","volume":"31","author":"Perruca","year":"1996","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.clinthera.2014.06.002_bib5","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1059-1311(02)00292-3","article-title":"An open-label study of levetiracetam at individualized doses between 1000 and 3000 mg\/day in adult patients with refractory epilepsy","volume":"12","author":"Abou-Khalil","year":"2003","journal-title":"Seizure"},{"key":"10.1016\/j.clinthera.2014.06.002_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2004.09.005","article-title":"Efficacy and safety of levetiracetam 1000-3000 mg\/day in patients with refractory partial onset seizures: a multicenter, open-label, single-arm study","volume":"63","author":"Beran","year":"2005","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.clinthera.2014.06.002_bib7","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0920-1211(03)00080-9","article-title":"The KEEPER trial: levetiracetam adjunctive treatment of partial-onset seizures in an open-label community-based study","volume":"54","author":"Morrell","year":"2003","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.clinthera.2014.06.002_bib8","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.pediatrneurol.2009.01.011","article-title":"Levetiracetam induced interstitial nephritis and renal failure","volume":"41","author":"Hurwitz","year":"2009","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.clinthera.2014.06.002_bib9","first-page":"161","article-title":"Fulminant liver failure in a patient on carbamazepine and levetiracetam treatment associated with status epilepticus","volume":"217","author":"Skopp","year":"2006","journal-title":"Arch Kriminol"},{"key":"10.1016\/j.clinthera.2014.06.002_bib10","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jocn.2011.08.007","article-title":"Levetiracetam-induced interstitial nephritis in a patient with glioma","volume":"19","author":"Mahta","year":"2012","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.clinthera.2014.06.002_bib11","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2165\/00023210-200216040-00005","article-title":"Interactions between antiepileptic drugs and hormonal contraception","volume":"16","author":"Crawford","year":"2002","journal-title":"CNS Drugs"},{"key":"10.1016\/j.clinthera.2014.06.002_bib12","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/cc2978","article-title":"Bench-to-bedside review: Rhabdomyolysis \u2013 an overview for clinicians","volume":"9","author":"Huerta-Alard\u00edn","year":"2005","journal-title":"Crit Care"},{"key":"10.1016\/j.clinthera.2014.06.002_bib13","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291814003580?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291814003580?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T01:56:34Z","timestamp":1538531794000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291814003580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":13,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S0149291814003580"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2014.06.002","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]}}}